daily semaglutide injection Day 2: Wegovy (Semaglutide 2.4 mg weekly injection) Class: GLP-1 receptor agonist Avg Weight Loss: ~15% of baseline weight Dosing: Weekly subcutaneous FDA Approved: June 2021 for chronic weight management Pros New clinical trial data from

Inoue N, Sugihara F, Wang X

Most patients naturally reduce their protein intake along with overall calories, but protein requirements actually increase during rapid weight loss

As GLP-1 medications like Ozempic, Wegovy, and Mounjaro continue to rise in popularity for diabetes management and weight loss, its important to be aware of the potential oral health complications that may come with them

57 years of age), but the difference was not statistically significant

avoid high-fat and high-fiber foods initially, as these slow stomach emptying further

The Shepherd of the Hills Expressway helps, but if your appointment falls during show let-out time, plan accordingly